Dermatology Made Easy is based on the most popular topics from DermNet NZ's vast array of material. The book combines the essential focus of the ‘Made Easy’ book series with the authority and knowledge base of DermNet NZ's unparalleled resources.
Author: Reviewed and updated by Dr Amanda Oakley Dermatologist, Hamilton, New Zealand; and Vanessa Ngan, Staff Writer; June 2014.
Anthrax is a bacterial infection caused by Bacillus anthracis. Untreated, up to one-fifth of infected individuals die of the disease. Prompt treatment with antibiotics is curative and most recover fully.
Anthrax is extremely rare in the developed world but sporadically occurs among farmers in Africa, the Middle East and the Caribbean. It can also infect workers in the wool, hair or bristle industries, butchers and gardeners.
Anthrax primarily affects sheep and cattle that ingest spores lying dormant in the pasture. Human infection can arise from spores entering the skin by inoculation through a minor injury, through the lungs by inhalation (wool sorter's disease) or by ingestion. Most anthrax infection (95%) is via the skin.
The most common form of anthrax is cutaneous anthrax, clinical features are described here.
Cutaneous anthrax develops usually between 1-7 days after skin exposure.
The infection occasionally results in a red streak tracking to nearby lymph glands (lymphangitis). These lymph nodes then often swell and become sore.
The appearance of anthrax can mimic the skin infections due to staphylococci and streptococci, and much less common viral infections due to cowpox and cat-scratch disease.
Anthrax becomes dangerous if it spreads widely through the blood stream. Symptoms of this include fever, headache and weakness. In mild cases, recovery occurs within three weeks. In severe infection, prostration, delirium, collapse and death often occur. The risk of anthrax spreading through the body is higher if the infection is acquired by inhalation or ingestion.
Cutaneous anthrax is treated with antibiotics. Treatment must be started straight away to reduce the chance of the anthrax spreading from the initial skin lesion.
In some cases it is necessary to surgically scrape off the black eschar from the anthrax ulcer. It is essential that this is done with antibiotic cover as interfering with the wound could encourage spread of the bacteria. If the eventual scar is unsightly, a plastic surgeon may be able to improve its appearance later.
A newer treatment for inhalational anthrax is the monoclonal antibody raxibacumab. It is used as part of a combination therapy with appropriate antibiotic agents.
Anthrax spores can survive for over 20 years in dry pasture and soil. Precautionary measures people can take include:
For people who have been exposed to anthrax but don’t have symptoms, prophylactic treatment with an antibiotic should be given to reduce the risk of infection. A 60-day oral course of penicillin, tetracycline or quinolone is recommended.
© 2018 DermNet New Zealand Trust.
DermNet NZ does not provide an online consultation service. If you have any concerns with your skin or its treatment, see a dermatologist for advice.